Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
Bristol-Myers Squibb(BMY) Benzinga·2024-09-27 19:56Bristol-Myers Squibb(BMY) Benzinga·2024-09-27 19:56
R1Bristol-Myers Squibb(BMY) Benzinga·2024-09-27 19:56